A new clinical score for disease activity in Langerhans cell histiocytosis

Pediatric Blood & Cancer
J DonadieuC Thomas

Abstract

To develop an objective tool for assessing disease activity in patients with Langerhans cell histiocytosis (LCH). Scoring system was developed and applied to a database containing information on 612 patients. At diagnosis, the score distribution was highly asymmetrical: the score was between 0 and 2 in 74% of cases, 3-6 in 16%, 7-10 in 3%, and more than 10 in 6%. The 5-year mortality rates were 1, 4.4, and 43.4%, respectively, among patients with initial scores of 0-2, 3-6, and >6. Stability or an increase of the score at 6 weeks was highly predictive of death among patients with initial scores above 6, while score stability had no significant impact on vital outcome among patients with low or moderate scores at diagnosis. This LCH disease activity score provides an objective tool for assessing disease severity, both at diagnosis and during follow-up and treatment.

References

Mar 1, 1990·Archives of Disease in Childhood·J McLellandJ Pritchard
Jul 1, 1995·The Journal of Pediatrics·R M Egeler, G J D'Angio
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Apr 30, 1998·Hematology/oncology Clinics of North America·M Aricò, R M Egeler
Apr 30, 1998·Hematology/oncology Clinics of North America·V Broadbent, H Gadner
Apr 19, 2000·Thorax·A TaziA J Hance
May 9, 2001·The Journal of Pediatrics·H GadnerUNKNOWN Histiocyte Society
Feb 12, 2002·Medical and Pediatric Oncology·Jorge BraierOscar Imventarza
Mar 6, 2004·The Journal of Pediatrics·Jean DonadieuUNKNOWN French LCH Study Group

❮ Previous
Next ❯

Citations

Jun 26, 2008·Pediatric Dermatology·Elizabeth K Satter, Whitney A High
Jun 6, 2013·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M HausteinF Sommer
May 15, 2012·Expert Opinion on Pharmacotherapy·Jean DonadieuEric Jeziorski
Jun 21, 2012·Expert Opinion on Pharmacotherapy·Milen Minkov
Feb 1, 2014·Seminars in Ultrasound, CT, and MR·Arjun Nair, David M Hansell
Jul 1, 2008·The Journal of Pediatrics·Milen MinkovUNKNOWN International LCH Study Group
Jun 28, 2008·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C Thomas, J Donadieu
Jun 24, 2008·Survey of Ophthalmology·Curtis E Margo, Darin R Goldman
Sep 27, 2008·Pediatric Blood & Cancer·C M Jantien Vrijmoet-WiersmaR Maarten Egeler
Jul 3, 2013·Pediatric Blood & Cancer·Stephane DucassouUNKNOWN Investigators of the French LCH Study Group
Mar 19, 2014·The Journal of Dermatology·Takeshi IwasakiHajime Iizuka
Sep 9, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sheila Weitzman, Jon Pritchard
Nov 18, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F BernardJ Donadieu
Jul 8, 2015·La Revue de médecine interne·A NéelA Tazi
Nov 9, 2011·The Korean Journal of Hematology·Won-Ik ChoiJong-Jin Seo
Nov 7, 2016·La Presse médicale·Jean Donadieu, Abdellatif Tazi
Nov 7, 2016·La Presse médicale·Mathilde de MenthonAbdellatif Tazi
Jan 15, 2017·La Presse médicale·Jean Donadieu, Sébastien Héritier
Jul 7, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sébastien HéritierJean Donadieu
Apr 27, 2017·British Journal of Haematology·Sébastien HéritierJean Donadieu
Sep 13, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean DonadieuSébastien Héritier
Mar 12, 2016·Blood·Jean-François EmileUNKNOWN Histiocyte Society
Jun 21, 2018·Journal of Cutaneous Pathology·Collin Matthew BlattnerAngela Bohlke
Nov 1, 2007·Expert Review of Endocrinology & Metabolism·Polyzois MakrasGregory A Kaltsas
Jul 10, 2019·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S HéritierJ Donadieu
Apr 27, 2021·Lancet·Jean-François EmileJulien Haroche

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.